Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Marcos de Lima, MD, UH Cleveland Medical Center, Cleveland, OH, provides an outlook on the current CAR T-cell climate including expanding the reach of therapies, determining the best model for manufacturing, and moving towards off-the-shelf therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.